BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Biegert GWG, Rosewell Shaw A, Suzuki M. Current development in adenoviral vectors for cancer immunotherapy. Mol Ther Oncolytics 2021;23:571-81. [PMID: 34938857 DOI: 10.1016/j.omto.2021.11.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Man YKS, Aguirre-hernandez C, Fernandez A, Martin-duque P, González-pastor R, Halldén G. Complexing the Oncolytic Adenoviruses Ad∆∆ and Ad-3∆-A20T with Cationic Nanoparticles Enhances Viral Infection and Spread in Prostate and Pancreatic Cancer Models. IJMS 2022;23:8884. [DOI: 10.3390/ijms23168884] [Reference Citation Analysis]
2 Priceman SJ, Cheema W, Adusumilli PS. Advancing together and moving forward: Combination gene and cellular immunotherapies. Molecular Therapy - Oncolytics 2022;25:330-334. [DOI: 10.1016/j.omto.2022.05.005] [Reference Citation Analysis]
3 Finck AV, Blanchard T, Roselle CP, Golinelli G, June CH. Engineered cellular immunotherapies in cancer and beyond. Nat Med 2022;28:678-89. [PMID: 35440724 DOI: 10.1038/s41591-022-01765-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]